Cyclic AMP response element modulator-1 (CREM-1) involves in neuronal apoptosis after traumatic brain injury

Area of Science:

• Neuroscience
• Molecular Biology
• Cell Biology

Background:

• The cyclic AMP response element-binding protein (CREB) family regulates gene transcription and is crucial for neuronal function.
• CREB regulates the apoptosis-suppressor gene bcl-2.
• Cyclic AMP response element modulator-1 (CREM-1) is a less-studied member of the CREB family.

Purpose of the Study:

• To investigate the role of CREM-1 in central nervous system injury and repair.
• To determine if CREM-1 is involved in neuronal apoptosis following traumatic brain injury (TBI).

Main Methods:

• An acute TBI model in adult rats was established.
• Western blot analysis and immunohistochemistry were used to detect CREM-1 expression.
• Immunofluorescent labeling and co-immunoprecipitation were employed to study CREM-1 localization and interactions.
• Small interfering RNA (siRNA) was used to knock down CREM-1 expression in a neuronal cell line (PC12).

Main Results:

• CREM-1 was significantly upregulated in the brain cortex following TBI.
• CREM-1 was localized in neuronal nuclei and co-localized with active-caspase-3, suggesting involvement in apoptosis.
• The association between CREM-1 and phosphorylated CREB (p-CREB) was enhanced in apoptotic neuronal cells.
• Knocking down CREM-1 reduced neuronal apoptosis, indicating a pro-apoptotic role.

Conclusions:

• CREM-1 expression is increased after TBI.
• CREM-1 may contribute to neuronal apoptosis following TBI, potentially by interacting with CREB.
• CREM-1 represents a potential therapeutic target for mitigating neuronal death after TBI.